Nami Surgical, the Scots medtech company and spinout from the University of Glasgow, has secured £3.2 million in investment and grant funding.

St Andrews-based impact investment firm Eos led the seed £2.5m round alongside the Investment Fund for Scotland, which is managed by UK private equity firm Maven and delivered by British Business Bank, Scottish Enterprise, and SIS ventures.

The spinout has also separately been awarded a grant amounting to £700,000 from Innovate UK, the United Kingdom’s national innovation agency.

Nami Surgical develops miniaturised ultrasonic medical devices for surgical applications, and supports medical device companies to deliver innovation in ultrasonic surgery.

In particular, the firm has introduced a high-performance, miniaturised ultrasonic scalpel, overcoming significant barriers in robotic-assisted surgery.

Traditionally favoured in laparoscopic procedures (keyhole surgeries), ultrasonic scalpels have been too large for effective use in robotic surgery, until Nami’s development.

Robotic surgeries, characterised by enhancing surgical precision and dexterity, can reduce patient trauma, post-operative pain, and recovery times.

As robotic surgery becomes the standard for various procedures, its global market is set to quadruple, reaching approximately $36 billion (£27b~) by 2032.

The integration of ultrasonic scalpels in robotic surgeries can set a new benchmark in surgical care, improving outcomes for patients.

CEO and co-founder of Nami Surgical, Nico Fenu, said: “Robot-assisted surgery has become increasingly popular in recent years and is now widely used in various surgical procedures including urology, gynaecology, and colorectal.

“We have pilot programmes running with healthcare and medical device groups worldwide, including in the United States, and we now look forward to the commercialisation phase with the support of our new investors.”

Recommended reading

• Investment Banks Forge Alliance for Scotland’s Economic Growth
• UK Tech Incorporations Hit Five-year High Last Quarter
• Aberdeen ROV Services Specialist Bought By US Company

“We are committed to close collaboration with clinicians and companies in the industry to translate their needs into novel devices that not only improve patient outcomes, but also drive ultrasonic surgery to the next level,” Fenu added.

“It’s an exciting time for us, and we are just getting started.”

Nami Surgical is a 2022 spinout from the University of Glasgow’s Centre for Medical and Industrial Ultrasonics.

The company was co-founded by CTO Dr Rebecca Cleary, and is chaired by life science and medtech non-executive director Albert Nicholl.